Navigation Links
Quest Diagnostics to Speak at the 26th Annual JPMorgan Healthcare Conference
Date:1/7/2008

MADISON, N.J., Jan. 7 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the nation's leading provider of diagnostic testing, information and services, announced that it is scheduled to speak at the 26th Annual JPMorgan Healthcare Conference on Tuesday, January 8, 2008, at the Westin St. Francis in San Francisco, California. The Quest Diagnostics presentation is scheduled to begin at 11:00 a.m. Eastern Time.

The presentation will be webcast live during the conference and will be available to registered investors on the following site: http://www.metameetings.com/webcasts/jpmorgan/healthcare08 and to the public at http://www.questdiagnostics.com. In addition, the archived webcast will be available within 24 hours after the presentation and will remain available until February 7, 2008.

Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at: http://www.questdiagnostics.com.

The statements in this press release which are not historical facts or information may
'/>"/>

SOURCE Quest Diagnostics
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ImmuneRegen Responds to Defense Threat Reduction Agency Request for Information
2. NovaQuest Advances Virtual Development Model With Strategic Investment in TOPIGEN Pharmaceuticals
3. Quest Diagnostics to Speak at the 2007 UBS Global Life Sciences Conference
4. VioQuest Pharmaceuticals to Present at BIO InvestorForum in San Francisco
5. Quest Diagnostics Joins National ePrescribing Patient Safety Initiative (NEPSI)
6. University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement
7. VioQuest Pharmaceuticals to Present at the Paramount BioSciences Healthcare Conference
8. Sinovac Requests Extension for Annual Shareholders Meeting
9. Maryland Stem Cell Commission Issues Nationwide Request for Applications for New Post-Doctoral Fellowship Grants
10. AmSurg Selects SciQuest Eprocurement Solution to Automate Purchasing of Medical Goods and Services
11. Quest PharmaTech to Receive $3,000,000 to Develop Oncology Products Based on its SonoLight Technology

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)...v. 20 Veridiam (www.veridiam.com) ...company category at the 2009 Workplace Excellence ...Society for Human Resources Management and recogni...tices. ,, Veridiam was one of nine winners, sel...ies, honored at the recent awards ceremony. San Di...
(Date:11/20/2009)... METTLER TOLEDO recently announced that a free we...ion Using At-Line Particle Characterization”...webinar, the application of in situ particle chara...e and optimize a series of roller compaction runs ...r compaction forces. , (P...
(Date:11/19/2009)...., Nov. 19 Dr. Mate Hidvegi, inven...ds to a press release issued on November 17 by Bir...r making false and self-serving statements about i.... Hidvegi stated from his office in Budapest, Hung... Avemar does not apply to AveULTRA, www.aveultra...
(Date:11/19/2009)...R, Germany, November 19 MONITORING...mber 16th, 2009 Flibanserin in the,indication trea...inson,s,disease for orphan drug status designation...pa-induced dyskinesia is a complication of the mai...ous burden to some of those,affected, since it may...
Breaking Biology Technology:Veridiam Wins Workplace Excellence Crystal Award in Mid-Size Company Category 2Roller Compaction Process Optimization Using At-Line Particle Characterization 2American BioSciences Rebuts Misleading Statements Made by Hungarian Competitor 2MONITORING FORCE GmbH Requests Acknowledgment of Flibanserin as "Orphan Drug" 2
...ITY, Feb. 14 /PRNewswire-FirstCall/ - Atrium Innov...ference call and webcast at 1:30 p.m.,Eastern time...ess release,of Atrium,s 2007 fourth quarter and fu...nts may access the call by using the following num...r via the Company,s website at, http://www.atrium-...
...y Finds Use of the Internet Now Dominates Quantita...ide, NEW YORK, Feb. 14 Three out of five market ... the US and abroad -- were,conducted online last y...l,Market Research Trends Study., The report, rele...esearch -- once the orphan of the industry -- is n...
...Feb. 14 Scimitar Equity Research, Inc.,(Scimitar)...Inc. (Nasdaq:,NTII), entitled, "When You Review St...; Each One is Different"., This review is availab...., Neurobiological Technologies, Inc. (NTII) is a...acquiring and developing central nervous system,re...
Other Biology Technology:Atrium Innovations to Hold 2007 Fourth Quarter and Full-Year Financial Results Conference Call and Webcast on February 29 2Technology Transforms Market Research in Pharmaceutical Industry 2Technology Transforms Market Research in Pharmaceutical Industry 3Neurobiological Technologies, Inc. (Nasdaq: NTII) Q2/08 Review Issued By Scimitar Equity Research, Inc. 2
(Date:11/20/2009)..., , Toxic dust: Toxins in coal-tar-based sealco...ated house dust, according to a USGS study. PAHs ...lecules found in oil, coal and tar deposits, and c...AHs are often found in house dust; however, the sp...ned. Researchers found that dust from indoor areas...
(Date:11/20/2009)...Chronic obstructive pulmonary disease (COPD), a re...itis or emphysema, is the fourth leading cause of ...D and while researchers have yet to find any real ...ch Institute at The University of Western Ontario ...ques to gain new insight into the disease. , ...
(Date:11/19/2009)...MADISON Leaf-cutter ants, which cultivate fungus ...e,s a new one to add to the list: the ant farmers,...-fixing bacteria to make their gardens grow. The f...l Science , documents a previously unknown symbio... into how leaf-cutter ants have come to dominate t...
Breaking Biology News(10 mins):From toxic dust and algae to ill winds from Africa 2From toxic dust and algae to ill winds from Africa 3From toxic dust and algae to ill winds from Africa 4From toxic dust and algae to ill winds from Africa 5Gaining a better picture of lung disease 2Like humans, ants use bacteria to make their gardens grow 2Federal Appeals Court Protects California Home Care Pay 51727 1Federal Appeals Court Protects California Home Care Pay 51727 2CSC Announces Agreement to Provide Billing Service to Littleton Internal Medicine Associates 51724 1Physicians Level of Concern for H1N1 Swine Flu Pandemic Highest Since April 51720 1Physicians Level of Concern for H1N1 Swine Flu Pandemic Highest Since April 51720 2Physicians Level of Concern for H1N1 Swine Flu Pandemic Highest Since April 51720 3
...e is the latest American Chemical Society (ACS) We...t has news from ACS, 34 peer-reviewed journals and...individual journal or the American Chemical Societ...Archive: http://portal.acs.org/portal/acs/corg/co...=223&content_id=CTP_006742&use_sec=true&sec_url_va...
...HINGTON, D.C. A class of Alzheimer,s disease drug...reduce damage caused by traumatic brain injury in ...cal Center report in an upcoming advance online pu...sults suggest that this class of drugs could poten... do-- prevent the long-term and continuing damage ...
... viscosity, or ,gloopiness, of different parts of ...blasted with light-activated cancer drugs, accordi... into how cancer cells die, published in Nature C...l the physical changes that occur inside cancer ce...mic Therapy (PDT). This cancer treatment uses ligh...
Other Biology News:American Chemical Society's weekly PressPac -- March 11, 2009 2American Chemical Society's weekly PressPac -- March 11, 2009 3American Chemical Society's weekly PressPac -- March 11, 2009 4American Chemical Society's weekly PressPac -- March 11, 2009 5American Chemical Society's weekly PressPac -- March 11, 2009 6Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 2Alzheimer's disease therapeutic prevents long-term damage from TBI in pre-clinical studies 3A sticky business -- how cancer cells become more 'gloopy' as they die 2
Rabbit Anti-Human CHYMOTRYPSIN Polyclonal Antibody, Unconjugated from AbD Serotec
rNeural Stem Cell (rNSC)Kit from AlphaGenix, Inc.
Sheep Anti-DEHYDROEPIANDROSTERONE (+DEAHS) Polyclonal Antibody, Unconjugated from AbD Serotec
4',6-diamidino-2-phenylindole, dihydrochloride (DAPI) *FluoroPure™ grade* from Molecular Probes (Invitrogen)
Biology Products: